Ministry of Food and Drug Safety 국민 안심이 기준입니다 YOUR SAFETY IS OUR STANDARD

Ministry of Food and Drug Safety 국민 안심이 기준입니다 YOUR SAFETY IS OUR STANDARD

home > Our Works > Bio&Cosmetics > Manufactures
Manufactures|Bio&Cosmetics|Our Works|Minisry of Food and Drug Safety

Biological Products

(Biologics) Janssen Vaccines Corp.
  • Registration Date 2016-10-14
  • Hit 5026

Company Information

1. Name

Janssen Vaccines Corp.

2. Website Address

www.janssen.com/korea

3. Location

(Songdo-dong)23, Harmony-ro 303beon-gil, Yeonsu-gu, Incheon, Korea

4. Contacts

+82-32-290-8400

5. References

Pharmaceutical Product Information

1. Brand Name

Hepavax-Gene® TF inj.

2. Active Ingredient

Purified hepatitis B surface antigen (host cell: Hansenular polymorpha YU305, vector: pGM834 (FMD promoter)

3. Indication

Immunization against hepatitis B

4. Information

1.0 mL of this product (1.0 mL; 20 mg) should be intramuscularly administered one time to adults. To neonates, infants and children, 0.5 mL (10 mg) should be intramuscularly administered one time.

1. Standard vaccination course:

1st vaccination: at the elected date

2nd vaccination: 1 month after the 1st vaccination

3rd vaccination: 6 months after the 1st vaccination

However, for those who need fast protection effect, such as those at high risk of exposure to hepatitis B virus or those who cannot follow the standard vaccination schedule, it is recommended to intramuscularly administer this product three times at 1-month interval.

5. Images



harmaceutical Product Information

3. Brand Name

Hepavax-Gene® TF Prefilled Syringe inj.

4. Active Ingredient

Purified hepatitis B surface antigen (host cell: Hansenular polymorpha YU305, vector: pGM834 (FMD promoter)

3. Indication

Immunization against hepatitis B

4. Information

1.0 mL of this product (1.0 mL; 20 mg) should be intramuscularly administered one time to adults. To neonates, infants and children, 0.5 mL (10 mg) should be intramuscularly administered one time.

1. Standard vaccination course:

1st vaccination: at the elected date

2nd vaccination: 1 month after the 1st vaccination

3rd vaccination: 6 months after the 1st vaccination

However, for those who need fast protection effect, such as those at high risk of exposure to hepatitis B virus or those who cannot follow the standard vaccination schedule, it is recommended to intramuscularly administer this product three times at 1-month interval.

5. Images

Attached File

Division

Written by 전형옥